Treatment of neonatal abstinence syndrome

Journal of Pediatric Health Care

Volumn 13, Issue 6 PART I, 1999, Pages 295-300

  Tran, Jennifer H ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIFFERENTIAL DIAGNOSIS; HUMAN; METHODOLOGY; NEWBORN; NEWBORN NURSING; NURSING ASSESSMENT; REVIEW; WITHDRAWAL SYNDROME;

DIAGNOSIS, DIFFERENTIAL; HUMANS; INFANT, NEWBORN; NEONATAL ABSTINENCE SYNDROME; NEONATAL NURSING; NURSING ASSESSMENT;

EID: 0033222329     PISSN: 08915245     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0891-5245(99)90023-8     Document Type: Article

References (32)

1. American Academy of Pediatrics, Committee on Fetus and Newborn, Committee on Drugs. (1983). Benzyl alcohol: Toxic agent in neonatal units. Pediatrics, 72, 356-358.
2. American Academy of Pediatrics, Committee on Drugs. (1998). Neonatal drug withdrawal. Pediatrics, 101, 1079-1088.
3. American Psychological Association, Committee on Drugs. (1983). Neonatal drug withdrawal. Pediatrics, 72, 895-902.
4. Bateman, D. A., Ng, S. K , Hansen, C. A., & Heagarty, M. C. (1993). The effects of intrauterine cocaine exposure in newborns American Journal of Public Health, 83, 190-193.
5. Briggs, G. G., Freeman, R. K., & Yaffe, S. J. (1994). A reference guide to fetal and neonatal risk: Drugs in pregnancy and lactation (4th ed). Baltimore. Williams & Wilkins.
6. Chasnoff, I. J. (1988). Newborn infants with drug withdrawal symptoms. Pediatrics in Review, 9, 273-277
7. Desmond, N. M., Schwanecke, R. P., Wilson, G. S., Yasunaga, S., & Burgdorff, I. (1972). Maternal barbiturate utilization and neonatal withdrawal symptomatology The Journal of Pediatrics, 80, 190-197.
8. Desmond, N. M., & Wilson, G. S. (1975). Neonatal abstinence syndrome: Recognition and diagnosis. Addictive Diseases An International Journal, 2, 113-121.
9. Dicker, M., & Leighton, E. A (1991). Trends in diagnosed drug problems among newborns: United States, 1979-1987. Drug and Alcohol Dependence, 28, 151-165
10. Doberczak, T. M., Kandall, S R., & Wilets, I. (1991) Neonatal opiate abstinence syndrome in term and preterm infants. The Journal of Pediatrics, 118, 933-937
11. Edelin, K. C., Gurganious, L., Golar, K., Oellerich, D., Kyei-Aboagye, K., & Hamid, M. A. (1988). Methadone maintenance in pregnancy: Consequences to care and outcome. Obstetrics & Gynecoiogy, 72, 399-404.
12. Finnegan, L. P., Kron, R. E., Connaughton, J. F., & Emich, J. P. (1975). Assessment and treatment of abstinence in the infant of the drug-dependent mother. International Journal of Clinical Pharmacology and Biopharmacy, 12, 19-32.
13. Finnegan, L. P., & Kaltenbach, K. (1992). Neonatal abstinence syndrome. In R. A. Hoekelman, S. B. Friedman, N. M. Nelson, H. M. Seidel, & M. L. Weitzman (Eds.), Primary Pediatric Care (pp. 1367-1378). St. Louis. Mosby.
14. Fried, P. A., & Makin, J. E. (1987). Neonatal behavioral correlates of perinatal exposure to marijuana, cigarettes and alcohol in low risk populations. Neurotoxicology and Teratology, 9, 1-7.
15. Gold, M. S., Redmond, D. E., & Kleker, H. D. (1978). Clonidine blocks acute opiate-withdrawal symptoms. Lancet, 2, 599-602.
16. Goodnow, C. (1989). Drugs cripple thousands before they're born. Seattle Post Intelligencer, p. 1D.
17. Green, M., & Suffet, F. (1981). The neonatal narcotic withdrawal index: A device for the improvement of care in abstinence syndrome. American Journal of Drug & Alcohol Abuse, 8, 203-213.
18. Hoder, E. L., Leckman, J. F., Ehrenhranz, R., Kleber, H., Cohen, D., & Poulsen, J. (1984). Clonidine treatment of neonatal narcotic abstinence syndrome. Psychiatry Research, 13, 243-251.
19. Kahn, E. J., Neumann, L. L., & Polk, G. A. (1969). The course of the heroin withdrawal syndrome in newborn infants treated with phenobarbital or chlorpromazine. The Journal of Pediatrics, 75, 495-500.
20. Kaltenbach, K., Berghella, V., & Finnegan, L. P. (1998). Opioid dependence during pregnancy: Effects and management. Obstetrics and Gynecology Clinics of North America, 25, 139-151.
21. Kaltenbach, K., & Finnegan, L. P. (1989). Children exposed to methadone in utero: Assessment of developmental and cognitive ability. The Annals of the New York Academy of Sciences, 562, 360-363.
22. Kandall, S. R., Doberczak, T. M., Mauer, K. R., Strashum, R. H., & Korts, D. C. (1983). Opiate vs CNS depressant therapy in neonatal drug abstinence syndrome. American Journal of Diseases of Children, 137, 378-382.
23. Khalsa, J. H., & Gfoerer, J. (1991). Epidemiology and health consequences of drug abuse among pregnant women. Seminars in Perinatology, 15, 265-270.
24. Kron, R. E., Litt, M., Eng, D., Phoenix, M. D., & Finnegan, L. P. (1976). Neonatal narcotic abstinence: Effects of pharmacotherapeutic agents and maternal drug usage on nutritive sucking behavior. The Journal of Pediatrics, 88, 637-641.
25. Levy, M., & Spino, M. (1993). Neonatal withdrawal syndrome: Associated drugs and pharmacologic management. Pharmacotherapy, 13, 202-211.
26. Lipsitz, P. J. (1975). A proposed narcotic withdrawal score for use with newborn infants: A pragmatic evaluation of its efficacy. Clinical Pediatrics, 14, 592-594.
27. Nielsen, H. C., Wiriyathian, S., Rosenfeld, R., Leveno, K., & Garriott, J. C. (1983). Chlorpromazine excretion by the neonate following chronic in utero exposure. Pediatric Pharmacology, 3, 1-5.
28. Oro, A. S., & Dixon, S. D. (1987). Perinatal cocaine and metamphetamine exposure. Maternal and neonatal correlates. The Journal of Pediatrics, 111, 571-578.
29. Rosen, T. S (1992). Infants of addicted mothers. In A. A. Fanaroff & R. J. Martin (Eds), Neonatal-perinatal medicine: Diseases of the fetus and infant (pp. 574-583). St. Louis: Mosby.
30. Rosen, T. S., & Pippenger, C. E. (1975). Disposition of methadone and its relationship to severity of withdrawal in the newborn. Addictive Diseases: An International Journal, 2, 169-178.
31. Taketomo, C. K., Hodding, J. H., & Kraus, D. M. (1999). Pediatric dosage handbook (6th ed). Hudson: Lexi-Comp.
32. Wagner, C. L., Katikaneni, L. D., Cox, T. H., & Ryan, R. M. (1998). The impact of perinatal drug exposure on the neonate. Obstetrics and Gynecology Clinics of North America, 25, 169-195.